文献速递中医内科中医妇科中药与中成药合理使用

基于UPLC-QTOF-MS、网络药理学和细胞实验探索清毒方治疗宫颈HR-HPV的机制

Exploring the mechanisms of Qingdu Fang for the treatment of cervical HR-HPV using UPLC-QTOF-MS, network pharmacology, and cell experimentation.
PubMed 文献 · Front Pharmacol · 2024-07-10

本研究采用UPLC-QTOF-MS鉴定清毒方成分,结合网络药理学预测其治疗宫颈HR-HPV的靶点与通路,并通过分子对接和H8细胞实验验证。结果鉴定出27种化合物、254个靶基因,核心靶点包括TP53、JUN、AKT1、STAT3、TNF和IL6;清毒方呈剂量依赖性抑制H8细胞增殖,诱导凋亡和细胞周期停滞,并抑制PI3K/AKT通路。

要点

  • 清毒方含27种化合物,作用于254个HR-HPV相关靶基因。
  • TP53、JUN、AKT1、STAT3、TNF、IL6为潜在核心靶点。
  • 清毒方通过抑制PI3K/AKT通路诱导H8细胞凋亡。

核心结论

  • 清毒方通过抗炎、抗氧化和促凋亡等多方面途径治疗HR-HPV,其诱导H8细胞凋亡的机制与抑制PI3K/AKT通路相关。

研究设计与样本

  • 研究采用UPLC-QTOF-MS分析清毒方成分,网络药理学预测靶点,分子对接和体外H8细胞实验验证。

主要发现

  • UPLC-QTOF-MS鉴定出清毒方27种化合物;网络药理学获得254个作用于宫颈HR-HPV的靶基因。
  • PPI分析提示TP53、JUN、AKT1、STAT3、TNF和IL6为潜在治疗靶点;分子对接显示2种化合物与AKT1强结合。
  • CCK-8和形态学观察显示清毒方呈剂量依赖性抑制H8细胞增殖;流式细胞术提示诱导凋亡和细胞周期停滞;Western blot显示抑制PI3K/AKT通路。

临床怎么用

  • 清毒方可能通过多靶点、多通路发挥抗HR-HPV作用,尤其涉及PI3K/AKT通路,可为后续临床或实验研究提供机制参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Qingdu Fang (QDF) is a traditional Chinese herbal formula with remarkable clinical effect in the treatment of HR-HPV, but its mechanism remains unclear. In this study, UPLC-QTOF-MS was used to detect its components, network pharmacology was used to explore the traditional Chinese medicine monomers and their related targets for the treatment of HR-HPV in QDF. Molecular docking and in vitro experiments were performed to verify the results. Methods: QDF constituents and active compounds were identified using UPLC-QTOF-MS analysis. TCMSP and GeneCard databases were used to identify active components, targets, and potential therapeutic targets in HR-HPV. PPI network was constructed using the String database to analyze protein-protein interactions. Cytoscape3.7.2 was used to construct PPI networks, while GO enrichment and KEGG pathway analyses with R. The effect of QDF on H8 cell proliferation was measured using the CCK-8 method, and apoptosis and cell cycle was assessed with flow cytometry. The effects of QDF on PI3K/AKT pathway were detected by Western blotting. Results: A total of 27 compounds were identified on QDF by UPLC-QTOF-MS. Base on Network pharmacology,a total of 254 target genes are involved in the action of QDF on cervical HR-HPV. PPI analysis suggested that TP53, JUN, AKT1, STAT3, TNF and IL6 were potential targets for QDF treatment of HR-HPV. Molecular docking shows that two compounds have strong binding activity with AKT1. CCK-8 and morphological observation have shown that QDF inhibits H8 cell proliferation in a dose-dependent manner. Flow cytometry experiments suggest that QDF induces apoptosis and cell cycle arrest in H8 cells. Western blotting experiments reveal that QDF inhibits the PI3K/AKT signaling pathway. Conclusion: QDF has a multi-faceted therapeutic approach for HR-HPV, targeting inflammation, oxidation, and apoptosis. It induces apoptosis in H8 cells by inhibiting the PI3K/AKT pathway.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wang S, Li G, Wang Z, et al. Exploring the mechanisms of Qingdu Fang for the treatment of cervical HR-HPV using UPLC-QTOF-MS, network pharmacology, and cell experimentation. Front Pharmacol. 2024. PMID: 39076591. doi:10.3389/fphar.2024.1415422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。